THROMBIN INHIBITOR MARKET ANALYSIS

Regional Analysis

Thrombin Inhibitor Market Regional Insights

• North America is expected to hold 35.0% market share during the forecast period due to the presence of a large patient population suffering from thrombosis-related disorders, the high healthcare expenditure, and the availability of advanced healthcare infrastructure in the region.
• Europe is expected to hold 24.4% market share due to the increasing prevalence of thrombosis-related disorders and the rising adoption of anticoagulant therapies for the same in the region.
• The Asia Pacific region is expected to witness 8.2% growth rate during the forecast period due to the increasing incidence of thrombosis-related disorders, the rising healthcare expenditure, and the growing focus on the development of advanced anticoagulant therapies in the region.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, Rest of Middle East
• Africa: South Africa, North Africa, Central Africa